Targeting the IL-17 Pathway in Inflammatory Disorders
Buch in deiner Nähe kaufen
Beschreibung
This book provides an overview of the discovery and structure of IL-17, including its pathogenesis and role in chronic inflammation and autoimmunity. To capture the latest developments and product approvals the book also discusses the therapeutic advances and looks at emerging therapies targeting the IL-17 pathway. IL-17 is a pro-inflammatory cytokine that has a key role in inflammation, autoimmunity, and host defense in a number of inflammatory disorders such as rheumatoid arthritis, psoriatic arthritis and psoriasis, ankylosing spondylitis, multiple sclerosis, and inflammatory bowel disease. The discovery of the IL-17-Th17 pathway has seen exciting development in the field of immunology and inflammation research, which has led to a number of recent regulatory approvals.
A comprehensive overview of the role of IL-17/Th17 in inflammatory disorders and discussion of the latest therapeutic advances targeting this pathway Includes the latest evidence-based treatment recommendations based on the most up-to-date research and clinical trial data A wide range of engaging images, tables, and diagrams illustrate the concepts discussed in the book Written by a renowned international expert on IL-17 research in the clinical setting
Autor*in
Cong-Qiu Chu
Themen in »Targeting the IL-17 Pathway in Inflammatory Disorders«
IL-17 Inflammatory disorders Chronic inflammation Autoimmunity Rheumatoid arthritis Psoriatic arthritis Psoriasis Ankylosing spondylitis pharmacotherapy